Akari Therapeutics Plc AKTX on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001541157
0001541157
EIN:
98-1034922
98-1034922
LEI:
(CF Office: 03 Life Sciences)
Business address:
22 BOSTON WHARF ROAD, FL 7, BOSTON, MA, 02210
Phone: (646) 350-0702
22 BOSTON WHARF ROAD, FL 7, BOSTON, MA, 02210
Phone: (646) 350-0702
Mailing address:
22 BOSTON WHARF ROAD, FL 7, BOSTON, MA, 02210
22 BOSTON WHARF ROAD, FL 7, BOSTON, MA, 02210
Category:
Non-accelerated filer
Smaller reporting company
Non-accelerated filer
Smaller reporting company
Former names:
- Celsus Therapeutics Plc. - filings through 2015-09-15
- Morria Biopharmaceuticals PLC - filings through 2013-06-20
Filings:
627 EDGAR filings since April 13, 2012
627 EDGAR filings since April 13, 2012
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- March 20, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- 9.01 - Financial Statements and Exhibits
- March 3, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 3.02 - Unregistered Sales of Equity Securities
- 9.01 - Financial Statements and Exhibits
- February 14, 2025 - SCHEDULE 13G: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 14, 2025 - SCHEDULE 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- January 13, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
Selected Filings
[+] 8-K (current reports)
- March 20, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- 9.01 - Financial Statements and Exhibits
- March 3, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 3.02 - Unregistered Sales of Equity Securities
- 9.01 - Financial Statements and Exhibits
- January 13, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
- December 18, 2024 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- December 16, 2024 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- December 12, 2024 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- November 19, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- November 15, 2024 - NT 10-Q: Notification of inability to timely file Form 10-Q or 10-QSB Open documentClick to Open document FilingOpen filingClick to Open filing
- August 19, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 15, 2024 - NT 10-Q: Notification of inability to timely file Form 10-Q or 10-QSB Open documentClick to Open document FilingOpen filingClick to Open filing
- May 15, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- March 29, 2024 - 10-K: Annual report for year ending December 31, 2023Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- June 3, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- March 24, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 24, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 24, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- February 14, 2025 - SCHEDULE 13G: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 14, 2025 - SCHEDULE 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- December 6, 2024 - SC 13D/A: General statement of acquisition of beneficial ownership - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 48 of 627 entries
Data source:
CIK0001541157.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
